Reinforcing its commitment to advancing cancer immunotherapy through research and education, the Society for Immunotherapy of ...

The Lustgarten Foundation and Break Through Cancer today announced the launch of a new Phase 1 clinical trial evaluating a next-generation KRAS-targeted lymph-node stimulating immunotherapy strategy ...

An experimental antibody has outperformed an established immunotherapy in a head-to-head trial for one of the harder-to-treat ...

A short burst of immunotherapy given before surgery, rather than the usual chemotherapy afterward, has kept a group of bowel ...

The cost-effectiveness of the immunotherapy drug pembrolizumab for patients with locally advanced head and neck squamous cell carcinoma may depend on biomarker results, according to a new study.

Immune checkpoint inhibitors, cancer vaccines and cellular therapies have reshaped oncology, yet most patients still do not ...

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined ...

A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given prior to ...

Brain tumors, remain among the most difficult cancers to treat, with limited therapeutic options and poor long-term survival despite advances in surgery, ...

Explore emerging mechanisms of immune checkpoint inhibitor resistance in hepatocellular carcinoma (HCC) and how combination ...

Given the role of circadian rhythms in regulating immune function, the researchers investigated whether the timing of ...

The parent of children with severe food allergies has said discovering oral immunotherapy treatment has been "life changing" ...